Human bio-monitoring and development of
potentially reduced exposure products (PREPS)

Lit cigarettes being tested

We recognise that it is possible to reduce certain constituents in tobacco smoke. This may in turn reduce the exposure of smokers to these constituents.

However, smokers should not assume that this results in any reduced risk. No government authority has adopted regulatory standards by which one cigarette could be regarded as having less risk than any other. It is our view that the relevant government authorities should define the objective criteria and predictive tests by which products can be judged to have potentially reduced risk.

We believe that a workable and effective regulatory framework cannot be developed without our knowledge and experience of tobacco products. As a responsible tobacco manufacturer, we consider that we share an obligation with regulators to enter this dialogue.

Measurements on biomarkers of exposure are key components in any approach to quantify exposure to smoke components.